U.S. Entertainment Stock News

NYSE:PHM
NYSE:PHMConsumer Durables

PulteGroup (PHM) Valuation Check After 15.7% One Month Share Price Decline

PulteGroup (PHM) has drawn attention after recent trading left the stock about 15.7% lower over the past month. This has prompted investors to reassess the US homebuilder’s valuation, returns, and underlying business mix. See our latest analysis for PulteGroup. The recent 15.7% one month share price decline and softer seven day move sit against a stronger backdrop, with a 1 year total shareholder return of 13% and a 3 year total shareholder return above 100%. This suggests momentum has cooled...
NYSE:DE
NYSE:DEMachinery

Is Deere’s High-Tech Equipment Revenue Beat Altering The Investment Case For Deere (DE)?

Deere recently reported past fourth-quarter results showing a 13% year-on-year revenue increase, outpacing analyst expectations by 5.9% on strong demand for its precision, automated, and connected agricultural equipment. This earnings beat underlines how Deere’s push into higher-tech machinery is reshaping its mix toward equipment that aims to boost farm efficiency and yields. We’ll now examine how Deere’s stronger-than-expected automated and connected equipment performance may influence the...
NYSE:RTX
NYSE:RTXAerospace & Defense

RTX Investors Weigh Rare Earth Risks Against Missile Program Strength

Pentagon officials are pushing suppliers to remove Chinese origin rare earth magnets from U.S. missile systems ahead of a legal ban that takes effect in 2027. RTX's Raytheon unit, which supplies missiles such as AMRAAM and Tomahawk, is directly exposed to this shift in sourcing requirements. Defense leaders have warned that the U.S. sector could face shortages of key rare earth materials if alternative supply chains are not secured in time. For investors watching NYSE:RTX, this rare earths...
NYSE:HLI
NYSE:HLICapital Markets

Assessing Houlihan Lokey (HLI) Valuation After Recent Weak Share Price Performance

Why Houlihan Lokey is on investors’ radar today Houlihan Lokey (HLI) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. In this context, investors are reassessing the US$9.8b investment bank’s fundamentals, including its US$2,648.0m in revenue, US$447.8m in net income, and a value score of 4, to gauge whether current pricing reflects its underlying advisory business...
NYSE:EFX
NYSE:EFXProfessional Services

Assessing Equifax (EFX) Valuation After MyEquifax App Launch And UK Motor Finance Redress Shift

Regulatory backdrop and product launch Equifax (EFX) has launched a free myEquifax app that helps consumers locate historic car finance agreements and share key details with lenders, just as the UK Financial Conduct Authority prepares its motor finance consumer redress scheme. See our latest analysis for Equifax. The myEquifax launch and recent governance debate around shareholder rights come against a weak share price backdrop, with a 30 day share price return of a 14.16% decline and a 1...
NYSE:CR
NYSE:CRMachinery

Do Macro Shocks Reveal Hidden Cyclicality In Crane (CR)’s Specialized Technology Story?

Earlier this week, specialized technology company Crane NXT (NYSE:CXT) saw its shares move alongside other industrial and technology names after reports of easing U.S.-Iran tensions pushed oil prices lower and lifted broader market sentiment. This reaction highlights how Crane NXT’s trading can be influenced by macro-geopolitical developments and commodity price shifts, even though its core business is focused on specialized industrial technologies. With improving geopolitical sentiment...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Why Ultragenyx (RARE) Is Down 14.4% After Positive Phase 3 DTX301 Gene Therapy Results

Ultragenyx Pharmaceutical Inc. recently reported positive Phase 3 Enh3ance data for DTX301, its investigational AAV8 gene therapy for ornithine transcarbamylase (OTC) deficiency, showing a statistically significant 18% reduction in 24-hour plasma ammonia versus placebo and an overall acceptable safety profile. A particularly important finding was that treated patients generally maintained normal ammonia levels despite lowering ammonia scavenger use and increasing protein intake, hinting at...
NYSE:CTVA
NYSE:CTVAChemicals

Corteva (CTVA) Valuation Check As Shares Show Building Momentum Over Multiple Time Frames

Why Corteva Is On Investors’ Radar Today Corteva (CTVA) has drawn attention recently as its shares trade around $80.58, with total returns over the past year and past 3 months indicating meaningful movement that investors may want to contextualize. See our latest analysis for Corteva. For context, Corteva’s recent 3.6% one day share price return and 19.7% 90 day share price return sit alongside a 31.6% one year total shareholder return and 81.3% five year total shareholder return, suggesting...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb Leans On AI ALS Pact As Valuation Question Persists

Bristol-Myers Squibb (NYSE:BMY) has expanded its partnership with insitro to pursue disease-modifying therapies for amyotrophic lateral sclerosis (ALS). The collaboration adds new ALS targets sourced from insitro’s AI driven Virtual Human platform and multimodal discovery approach. The partners aim to accelerate discovery and development of multiple ALS candidates in an area with significant unmet medical need. Bristol-Myers Squibb, trading at about $57.39, is extending this AI focused...
NYSE:ECL
NYSE:ECLChemicals

Is Ecolab (ECL) Pricing In Too Much Quality After Recent Share Price Pullback?

Wondering if Ecolab at around US$264 a share is offering fair value or asking too much for quality? This article unpacks what the current price really implies. The stock has seen a 3% decline over the last week and a 13% decline over the last month, while still sitting on a 6.4% 1 year return and a 70.4% 3 year return from earlier levels. Recent headlines around Ecolab have focused on its role as a major player in water, hygiene and infection prevention solutions and its position within the...
NYSE:EPR
NYSE:EPRSpecialized REITs

Is EPR Properties (EPR) Attractive After Recent Share Price Volatility And DCF Valuation Gap

Wondering whether EPR Properties at around US$50.35 is offering good value or not right now? This article walks through the numbers so you can judge how the current price compares with its fundamentals. The stock has recently been volatile, with a 10.5% decline over the last 7 days and a 12.8% decline over the last 30 days, set against a 5.2% return over 1 year, 70.4% over 3 years and 49.6% over 5 years. Recent headlines around EPR Properties have focused on its position within the real...
NYSE:COR
NYSE:CORHealthcare

Cencora Expands Retina Network With EyeSouth Deal And Earnings Focus

Cencora (NYSE:COR) has agreed to acquire the retina business of EyeSouth Partners. Affiliated physicians are expected to join Retina Consultants of America, where Cencora already holds a majority stake. The deal is expected to be accretive to adjusted earnings, subject to regulatory approval. Cencora is extending its reach in ophthalmology by integrating EyeSouth Partners' retina business into Retina Consultants of America, further concentrating its presence in specialist care. The...
NYSE:CCL
NYSE:CCLHospitality

Dividend Return And Luxury Tie‑Ups Could Be A Game Changer For Carnival Corporation (CCL)

Carnival Corporation & plc recently reported a strong quarter, beating analyst earnings expectations and reinstating its dividend, while luxury brands Seabourn and Cunard announced new partnerships with The Atlantic and stylist Micaela Erlanger to enrich onboard experiences. Together, these developments highlight Carnival’s emphasis on premium, experience‑led offerings and shareholder returns, potentially reinforcing its positioning within leisure travel. Next, we’ll explore how the...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos Expands Rural Health Reach While Shares Trade Below Valuation Estimates

Leidos QTC Health Services, part of Leidos Holdings (NYSE:LDOS), is rolling out technology enabled healthcare solutions to rural communities. The initiative includes mobile clinics and AI powered telehealth platforms designed to reach patients with limited local medical resources. This expansion reflects Leidos' use of its digital capabilities in a public health context beyond its core work in defense and government contracts. For you as an investor, this move broadens the picture of what...
NYSE:ICE
NYSE:ICECapital Markets

Assessing Intercontinental Exchange (ICE) Valuation After Recent Mixed Share Price Performance

What Intercontinental Exchange’s recent performance means for investors Intercontinental Exchange (ICE) has seen mixed share performance recently, with a 1.2% gain over the past month but a 4.2% decline over the past 3 months, prompting closer attention from investors. See our latest analysis for Intercontinental Exchange. At a share price of $155.82, Intercontinental Exchange’s recent 7 day share price return of a 3.1% decline and year to date share price return of a 2.6% decline contrast...
NYSE:NET
NYSE:NETIT

Is It Too Late To Consider Cloudflare (NET) After Its Recent Share Price Surge

For investors wondering if Cloudflare at US$213.15 is priced for perfection or still offers value, this article walks through what the current market price may be implying. The stock has a 7 day return of 0.8%, a 30 day return of 20.3%, is up 8.7% year to date, and has returned 67.2% over 1 year and 277.4% over 3 years. This naturally raises questions about what is already baked into expectations. Recent coverage has focused on Cloudflare's role in internet security and content delivery,...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum Governance Vote And What It Could Mean For Valuation

Marathon Petroleum (NYSE:MPC) has scheduled a shareholder vote on a proposed amendment to its Certificate of Incorporation at the 2026 Annual Meeting. The proposal focuses on corporate governance terms that could influence shareholder rights and future decision making at the company. Investors will have the opportunity to review and vote on the amendment as part of the formal meeting agenda. Marathon Petroleum operates as a large US refiner and fuel marketer, so changes to its governance...
NYSE:HP
NYSE:HPEnergy Services

Helmerich & Payne’s CFO Succession and New CEO Could Be A Game Changer For HP

Helmerich & Payne, Inc. has reshaped its leadership team, with Trey Adams appointed President and CEO in early March 2026 and longtime finance chief Kevin Vann set to retire as CFO and SVP on June 30, 2026, to be succeeded by current Vice President of Corporate Finance and Treasurer, Todd Scruggs, on July 1, 2026. This carefully phased transition, with Vann remaining as senior advisor through year-end 2026 and Scruggs bringing deep energy-sector finance and capital allocation experience,...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Will Omnes Capital’s AI DealCloud Adoption Shift Intapp’s (INTA) Investment Narrative Toward Institutional Entrenchment?

Earlier in March, Intapp announced that Omnes Capital, a European private equity firm focused on the energy transition with more than €6.70 billion in assets under management, adopted its DealCloud platform to centralize marketing, investor relations, and data-driven decision-making. The decision by Omnes to integrate AI-enabled automation and firmwide intelligence into everyday workflows highlights how Intapp’s DealCloud is being used to modernize relationship management and reduce manual...
NYSE:NKE
NYSE:NKELuxury

Nike’s Profit Hit And CEO Share Buy Spark Recovery Debate

Nike, Inc. (NYSE:NKE) has reported a sharp drop in full year FY2025 revenue and net income, pressured by higher tariffs and heavier discounting. The profitability squeeze highlights material operational and macroeconomic headwinds affecting the business. CEO Elliott Hill has made a sizable personal purchase of Nike shares, signaling confidence in the company during a challenging period. Analysts are discussing the potential for a multi year recovery in light of the weaker results and the...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

How Ciena Partnership’s Quantum-Secure Networking Demo Could Shape Quantum Computing’s (QUBT) Commercial Trajectory

Earlier in March 2026, Ciena and Quantum Computing Inc. held a joint live demonstration at OFC 2026 showcasing an integrated quantum-secure communications architecture that combines quantum key distribution, quantum and classical authentication, and high-performance AES-256-GCM optical encryption up to 1.6 Tb/s on Ciena’s Waveserver platform. An interesting aspect is QCi’s time-frequency entanglement-based QKD using telecom-band photons and its Quantum Zero Knowledge Proof hardware for...
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

Is It Time To Reassess Firefly Aerospace (FLY) After Its Recent Price Swings?

If you are wondering whether Firefly Aerospace at around US$23.73 is a bargain, expensive, or somewhere in between, the valuation story is where the answer starts to take shape. The stock has had a mixed short term run, with an 18.8% return over the past 30 days but a 3.5% decline over the last week and a roughly flat return of 0.1% so far this year. Recent coverage around Firefly Aerospace has focused on its position in the wider Aerospace and Defense space and how investors are treating...
NYSE:GRC
NYSE:GRCMachinery

Gorman-Rupp (GRC) Valuation Check After Strong 3 Month Share Price Momentum

Recent performance snapshot Gorman-Rupp (GRC) has drawn investor attention after a strong past 3 months, with the share price up about 25%, while the performance over the past month has been slightly negative. See our latest analysis for Gorman-Rupp. Zooming out, the recent 1 day and 7 day share price gains sit against a year to date share price return of about 30% and a 1 year total shareholder return close to 77%, suggesting momentum has been building over both shorter and longer...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Is It Time To Reassess Workday (WDAY) After A 48.9% One-Year Share Price Decline

If you are wondering whether Workday's current share price reflects its true worth, this article walks through the key numbers investors are watching. Workday recently closed at US$129.29, with returns of 4.4% decline over the past week, 6.2% decline over the last month, and 37.2% decline year to date, while the 1 year return sits at 48.9% decline. These moves have kept attention on how the market is currently pricing Workday, with recent coverage focusing on its role in enterprise software...